Ibyra 150 mg tablets contain the active ingredient Olaparib, which is a targeted anti-cancer medication belonging to a class of drugs known as PARP (poly [ADP-ribose] polymerase) inhibitors. It works by blocking specific enzymes that cancer cells use to repair their damaged DNA, ultimately causing the cancer cells to die off and slowing tumor growth.